Safe Antihistamines in First Trimester
Both first-generation and second-generation antihistamines are generally safe during the first trimester, with second-generation agents (particularly cetirizine and loratadine) now preferred due to comparable safety data and better tolerability profiles. 1
Recommended Antihistamines
Second-Generation Antihistamines (Preferred)
The accumulated safety data for second-generation antihistamines during first trimester exposure is now comparable to first-generation agents, making them the preferred choice 1:
- Cetirizine: Extensive safety data from over 186,000 exposures in Scandinavian registries with no increased risk of major malformations 2, 3
- Loratadine: Well-established safety profile with large cohort data supporting first trimester use 4, 5
- Fexofenadine: No reports of increased congenital malformations, though human epidemiologic studies are more limited 1, 6
A 2017 meta-analysis of 37 studies found no increased risk of major malformations (OR 1.07; 95% CI 0.98-1.16), spontaneous abortions, prematurity, or low birth weight with H1 antihistamines 7.
First-Generation Antihistamines (Alternative)
While historically recommended as first-choice agents due to longevity of use, their sedative effects and impaired performance characteristics make them less desirable 1:
- Chlorpheniramine: Long safety record with observed safety data
- Diphenhydramine: Frequently used with generally good safety data, BUT one case-control study suggested an association with cleft palate that has not been sufficiently refuted 1
Antihistamines to Avoid or Use Cautiously
Hydroxyzine should be used cautiously during the first trimester based on animal data 1
Limited data antihistamines (insufficient human pregnancy studies):
- Desloratadine (though recent 2020 data shows no increased risk) 4
- Azelastine
- Levocetirizine
- Olopatadine (though 2026 cohort data is reassuring) 6
Intranasal antihistamines should be avoided during pregnancy 5
Clinical Decision Algorithm
Step 1: Choose second-generation antihistamines as first-line
- Primary choices: Cetirizine or loratadine (most robust human safety data)
- Alternative: Fexofenadine (if patient has prior favorable response)
Step 2: If second-generation agents unavailable or ineffective
- Consider chlorpheniramine
- Avoid diphenhydramine if possible due to cleft palate concern
- Never use hydroxyzine
Step 3: Avoid combining with oral decongestants
- Phenylephrine and pseudoephedrine have conflicting reports of associations with gastroschisis and small intestinal atresia during first trimester 1
Important Caveats
- The first trimester is the critical period for concern about congenital malformations due to organogenesis 1
- FDA pregnancy risk categories are based largely on animal studies with limited human data—prioritize human cohort and case-control studies when available 1
- Recent large-scale studies (>1.2 million pregnancies) show no statistically significant associations between second-generation antihistamines and major congenital malformations, spontaneous abortions, or premature births 3
- The relative infant dose of cetirizine and loratadine remains below the 5% safety threshold 3